Esther Brandon

2.8k total citations
25 papers, 1.7k citations indexed

About

Esther Brandon is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Pharmacology. According to data from OpenAlex, Esther Brandon has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Health, Toxicology and Mutagenesis and 6 papers in Pharmacology. Recurrent topics in Esther Brandon's work include Pharmacogenetics and Drug Metabolism (6 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Esther Brandon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Esther Brandon collaborates with scholars based in Netherlands, Spain and United States. Esther Brandon's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Irma Meijerman, Agnes G. Oomen, Adriënne J.A.M. Sips, Joanna Wragg, Tom Van de Wiele, Christian Grøn, Mark Cave and Sébastien Denys and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Food and Chemical Toxicology.

In The Last Decade

Esther Brandon

25 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Brandon Netherlands 17 484 400 349 270 187 25 1.7k
Francesco Barbato Italy 30 755 1.6× 477 1.2× 861 2.5× 143 0.5× 190 1.0× 77 2.8k
Walter Brand Netherlands 18 274 0.6× 182 0.5× 314 0.9× 144 0.5× 122 0.7× 32 1.3k
Daniel Junqueira Dorta Brazil 23 514 1.1× 276 0.7× 489 1.4× 92 0.3× 262 1.4× 80 1.9k
Jos Bessems Netherlands 23 576 1.2× 189 0.5× 341 1.0× 784 2.9× 220 1.2× 52 2.1k
Kaiser Jamil India 26 383 0.8× 169 0.4× 468 1.3× 193 0.7× 506 2.7× 128 2.0k
Jochem Louisse Netherlands 28 773 1.6× 178 0.4× 794 2.3× 251 0.9× 248 1.3× 83 2.5k
Muhammad Umar Ijaz Pakistan 19 235 0.5× 240 0.6× 233 0.7× 159 0.6× 185 1.0× 127 1.2k
Ssu‐Ching Chen Taiwan 29 247 0.5× 279 0.7× 1.1k 3.1× 224 0.8× 391 2.1× 75 2.5k
Lynne T. Haber United States 21 594 1.2× 191 0.5× 392 1.1× 74 0.3× 193 1.0× 58 1.7k

Countries citing papers authored by Esther Brandon

Since Specialization
Citations

This map shows the geographic impact of Esther Brandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Brandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Brandon more than expected).

Fields of papers citing papers by Esther Brandon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Brandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Brandon. The network helps show where Esther Brandon may publish in the future.

Co-authorship network of co-authors of Esther Brandon

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Brandon. A scholar is included among the top collaborators of Esther Brandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Brandon. Esther Brandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandon, Esther, et al.. (2024). A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions. Frontiers in Pharmacology. 15. 1412692–1412692. 2 indexed citations
2.
Brandon, Esther, J.C.H. van Eijkeren, Marc Tienstra, et al.. (2015). Implementation of toxicokinetics in toxicity studies – Toxicokinetics of 4-methylanisole and its metabolites in juvenile and adult rats. Regulatory Toxicology and Pharmacology. 73(1). 55–64. 5 indexed citations
3.
Gibb, Herman J., Brecht Devleesschauwer, P. Michael Bolger, et al.. (2015). Asian Implications of Aflatoxin and Dioxin Foodborne Chemical Exposures Based on World Health Organization Estimates. SHILAP Revista de lepidopterología. 2 indexed citations
4.
Brandon, Esther, et al.. (2014). Bioaccessibility of vitamin A, vitamin C and folic acid from dietary supplements, fortified food and infant formula. International Journal of Food Sciences and Nutrition. 65(4). 426–435. 29 indexed citations
5.
Geraets, Liesbeth, Agnes G. Oomen, Petra Krystek, et al.. (2014). Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Particle and Fibre Toxicology. 11(1). 30–30. 228 indexed citations
6.
Brandon, Esther, et al.. (2014). Arsenic: bioaccessibility from seaweed and rice, dietary exposure calculations and risk assessment. Food Additives & Contaminants Part A. 31(12). 1993–2003. 50 indexed citations
7.
Brandon, Esther, Astrid S. Bulder, J.G.M. van Engelen, et al.. (2013). Does EU legislation allow the use of the Benchmark dose (BMD) approach for risk assessment?. Regulatory Toxicology and Pharmacology. 67(2). 182–188. 12 indexed citations
8.
Hoogenboom, L.A.P., Patrick P. J. Mulder, Marco J. Zeilmaker, et al.. (2011). Carry-over of pyrrolizidine alkaloids from feed to milk in dairy cows. Food Additives & Contaminants Part A. 28(3). 359–372. 86 indexed citations
9.
Wragg, Joanna, Mark Cave, N. T. Basta, et al.. (2011). An inter-laboratory trial of the unified BARGE bioaccessibility method for arsenic, cadmium and lead in soil. The Science of The Total Environment. 409(19). 4016–30. 319 indexed citations
10.
Brandon, Esther, et al.. (2010). Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach. Current Gene Therapy. 10(2). 91–106. 11 indexed citations
11.
Goicoechea, Encarnación, Esther Brandon, Marco Blokland, & Marı́a D. Guillén. (2010). Fate in digestion in vitro of several food components, including some toxic compounds coming from omega-3 and omega-6 lipids. Food and Chemical Toxicology. 49(1). 115–124. 56 indexed citations
12.
Tiesjema, Birgitte, et al.. (2010). Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient HAdV-5: A Qualitative Modelling Approach. Current Gene Therapy. 10(2). 107–127. 14 indexed citations
13.
Kabak, Bülent, Esther Brandon, İşıl Var, Marco Blokland, & Adriënne J.A.M. Sips. (2009). Effects of probiotic bacteria on the bioaccessibility of aflatoxin B1and ochratoxin A using anin vitrodigestion model under fed conditions. Journal of Environmental Science and Health Part B. 44(5). 472–480. 74 indexed citations
14.
Jacobs, Miriam N., Wim Janssens, Ulrike Bernauer, et al.. (2008). The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors. Current Drug Metabolism. 9(8). 796–826. 43 indexed citations
15.
Brandon, Esther, Rolf W. Sparidans, Irma Meijerman, et al.. (2006). In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug. Investigational New Drugs. 25(1). 9–19. 15 indexed citations
16.
Brandon, Esther, Rolf W. Sparidans, Luis López Lázaro, et al.. (2005). Structure elucidation of aplidine metabolites formed in vitro by human liver microsomes using triple quadrupole mass spectrometry. Journal of Mass Spectrometry. 40(6). 821–831. 18 indexed citations
17.
Brandon, Esther, Agnes G. Oomen, C.J.M. Rompelberg, et al.. (2005). Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment. Regulatory Toxicology and Pharmacology. 44(2). 161–171. 101 indexed citations
18.
19.
20.
Brandon, Esther, et al.. (2004). In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug. Investigational New Drugs. 22(3). 241–251. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Barbato Breakdown of academic impact, for papers by Walter Brand Breakdown of academic impact, for papers by Daniel Junqueira Dorta Breakdown of academic impact, for papers by Jos Bessems Breakdown of academic impact, for papers by Kaiser Jamil Breakdown of academic impact, for papers by Jochem Louisse Breakdown of academic impact, for papers by Muhammad Umar Ijaz Breakdown of academic impact, for papers by Ssu‐Ching Chen Breakdown of academic impact, for papers by Lynne T. Haber
Rankless by CCL
2026